BioSpace News Archive

Pharm Country

Advaxis to Present Poster Entitled “Natural Killer (NK) Cells Orchestrate the Antitumor Activities of Listeria monocytogenes (Lm)-Based Immunotherapy” at Society for Immunotherapy of Cancer Annual Meeting

Results Show Treatment of Tumor-Bearing Mice with Axalimogene Filolisbac (AXAL) Leads to Natural Killer Cell Activation and Other Important Immune-Related Effects

November 6, 2018
·
4 min read
Biotech Bay

NGM Bio Announces Multiple Presentations at AASLD’s The Liver Meeting®, Including New NASH Histology Data from the Phase 2 Trial of NGM282 and Topline Phase 1b Data for NGM313

NGM Biopharmaceuticals, Inc. today announced multiple presentations at AASLD’s The Liver Meeting® 2018, which will take place in San Francisco from November 9-13, 2018.

November 6, 2018
·
4 min read
Drug Development

Alkermes Presents New Data on ALKS 4230 at Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

Initial Clinical Data From Ongoing Monotherapy Dose-Escalation Stage of Phase 1 Study to be Presented

November 6, 2018
·
8 min read
UroGen Pharma to Present at November 2018 Investor Conferences

UroGen Pharma Ltd. today announced that management will present at two investor conferences in November 2018

November 6, 2018
·
1 min read
Biotech Bay

Atreca to Present Data Further Demonstrating Ability of the Company’s Discovery Engine to Identify Patient-Derived Antibodies that Target Non-Autologous Tumor Tissue

Study to be presented at the Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting

November 6, 2018
·
3 min read
Drug Development

Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate

VE800 shown to induce cytotoxic T cells and a systemic immune response both as a monotherapy and in combination with checkpoint inhibitors

November 6, 2018
·
5 min read
Business

Jnana Therapeutics Announces Appointment of Joanne Kotz, Ph.D. as Chief Executive Officer

Jnana Therapeutics today announced that Joanne Kotz, Ph.D., a company co-founder, has been named Chief Executive Officer. Dr. Kotz has served as Jnana’s president since December 2017.

November 6, 2018
·
2 min read
CENTOGENE Announces Updates to CentoMD®, World’s Largest Genetic Mutation Database of Rare Diseases

CENTOGENE today announced updates to CentoMD®, the world’s largest genetic mutation database of rare diseases.

November 6, 2018
·
2 min read
Business

American Shared Hospital Services to Report Third Quarter 2018 Results on November 8, 2018

Management to hold a conference call at 3:00pm EST

November 6, 2018
·
1 min read
Drug Development

Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting

Data highlight the differential advantages of Synthetic Biotic approach designed to activate the local innate immune system for the potential treatment of a variety of solid tumors

November 6, 2018
·
8 min read